An evolutionary perspective on anti-tumor immunity

An evolutionary perspective on anti-tumor immunity

Item
http://www.wikidata.org/entity/Q36522859
Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytesEnhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case studyInduction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective studyInferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models.Eavesdropping on altered cell-to-cell signaling in cancer by secretome profilingAcquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.Immune biomarkers: how well do they serve prognosis in human cancers?Cancer immunotherapy and next-generation clinical immune assessment.
P2860

An evolutionary perspective on anti-tumor immunity

Item
http://www.wikidata.org/entity/Q36522859
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
An evolutionary perspective on anti-tumor immunity
@ast
An evolutionary perspective on anti-tumor immunity
@en
type
label
An evolutionary perspective on anti-tumor immunity
@ast
An evolutionary perspective on anti-tumor immunity
@en
prefLabel
An evolutionary perspective on anti-tumor immunity
@ast
An evolutionary perspective on anti-tumor immunity
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
An evolutionary perspective on anti-tumor immunity
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P932